布地奈德混悬液雾化吸入治疗对急性咽喉炎临床疗效及安全性评估
Clinical efficacy and safety evaluation of budesonide suspension aerosol inhalation in the treatment of acute pharyngitis
ES评分 0
| DOI |
10.12208/j.ijcr.20230042 |
| 刊名 |
International Journal of Clinical Research
|
| 年，卷(期) |
2023, 7(1) |
| 作者 |
|
| 作者单位 |
雅安职业技术学院附属医院 四川雅安 ;
|
| 摘要 |
评估布地奈德混悬液雾化吸入治疗对急性咽喉炎临床效果与安全性。方法 方便撷取2021年1月至2022年7月时段内就本院行急性咽喉炎治疗的患者118例，依据SPSS22.0软件生成随机分组序列后均分为两组；分别予清开灵颗粒与布地奈德混悬液雾化吸入治疗。判别比对两组症状缓解时间、血清炎症因子以及临床效果。结果 治疗后，观察组2项炎症指标均低于对照组（P<0.001），咽痛、咳嗽以及声嘶咽痒消失时间均短于对照组（P<0.001），总体疗效（96.61%）高于对照组（83.05%）（P<0.05）。结论 针对急性咽喉炎予以布地奈德混悬液雾化吸入效果优异，整体安全性较高。
|
| Abstract |
Objective: To evaluate the clinical efficacy and safety of budesonide suspension aerosol inhalation in the treatment of acute pharyngitis. Methods: From January 2021 to July 2022, 118 patients with acute pharyngolaryngitis in our hospital were collected and randomly divided into two groups according to SPSS 22.0 software; Qingkailing granules and budesonide suspension were inhaled respectively. The symptom relief time, serum inflammatory factors and clinical effects of the two groups were compared. Results: After treatment, the three inflammatory indexes in the observation group were lower than those in the control group (P<0.001), and the disappearance time of pharyngodynia, cough and hoarseness and itching was shorter than that in the control group (P<0.001). The overall efficacy (96.61%) was higher than that in the control group (83.05%) (P<0.05). Conclusion: The atomization inhalation of budesonide suspension for acute pharyngitis is effective and safe.
|
| 关键词 |
急性咽喉炎；布地奈德混悬液；雾化吸入；效果
|
| KeyWord |
Acute Pharyngolaryngitis; Budesonide Suspension; Atomization Inhalation; Effect
|
| 基金项目 |
|
| 页码 |
137-139 |
蒋图彬*.
布地奈德混悬液雾化吸入治疗对急性咽喉炎临床疗效及安全性评估 [J].
国际临床研究杂志.
2023; 7; (1).
137 - 139.